^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BAT8010

    i
    Other names: BAT8010
    Associations

    News

    Trials
    Company:
    Bio-Thera Solutions
    Drug class:
    Topoisomerase I inhibitor, HER2-targeted antibody-drug conjugate
    Related drugs:
    Associations

    News

    Trials
    9d
    An Evaluation of BAT 8010 for Injection in Combination With BAT 1006 in Locally Advanced or Metastatic Entities Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of the Tumor in Patients Multicenter, Open Phase Ib/IIa Clinical Study (clinicaltrials.gov)
    P1/2, N=108, Not yet recruiting, Bio-Thera Solutions
    New P1/2 trial • Combination therapy • Metastases
    |
    BAT1006 • BAT8010
    12ms
    Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients (clinicaltrials.gov)
    P1, N=109, Recruiting, Bio-Thera Solutions
    New P1 trial
    |
    HER-2 (Human epidermal growth factor receptor 2)
    |
    HER-2 expression
    |
    BAT8010